David Mcwilliams serves as Executive at Greenwich LifeSciences, Inc., where they oversee executive responsibilities. Since joining the company, David Mcwilliams has executed 7 insider transactions totaling $28.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 14, 2021 involved purchasing 200 shares valued at $5.5K.
David Mcwilliams currently holds 620,301 shares of Greenwich LifeSciences, Inc. (GLSI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Mcwilliams has been a net buyer of GLSI stock. They have purchased $28.6K and sold $0 worth of shares.
David Mcwilliams's most recent insider trade was on Dec 14, 2021, when they purchased 200 shares at $27.56 per share.
Get notified when new Form 4 filings are submitted
| $5.40 |
| Discretionary |
| Sep 29, 2020 | GLSI | $15.0K | Purchase | 2,608 | $5.75 | Discretionary |
| Sep 29, 2020 | GLSI | $0 | Option Exercise | 7,609 | $N/A | Discretionary |
| Sep 29, 2020 | GLSI | $0 | Option Exercise | 3,746 | $N/A | Discretionary |
| Sep 29, 2020 | GLSI | $0 | Option Exercise | 7,663 | $N/A | Discretionary |
| Sep 29, 2020 | GLSI | $0 | Option Exercise | 152,604 | $N/A | Discretionary |